Skip to content
10-Q

Quarterly Report

IGC Pharma, Inc. IGC

0001185185-25-000137

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Feb 10, 2025 79.69M sh
Shares Diluted Q3 2025 · Dec 31, 2024 77.63M sh
Shares Diluted Q3 2025 · Dec 31, 2024 75.49M sh
Shares Diluted Q3 2025 · Dec 31, 2023 63.73M sh
Shares Diluted Q3 2025 · Dec 31, 2023 57.04M sh
Capex Q3 2025 · Dec 31, 2024 $94K
Capex Q3 2025 · Dec 31, 2023 $123K
Operating Cash Flow Q3 2025 · Dec 31, 2024 −$4.07M
Operating Cash Flow Q3 2025 · Dec 31, 2023 −$4.67M
Long Term Debt Q3 2025 · Dec 31, 2024 $134K
Long Term Debt Q3 2025 · Mar 31, 2024 $137K
Short Term Debt Q3 2025 · Dec 31, 2024 $3K
Short Term Debt Q3 2025 · Mar 31, 2024 $3K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $470K
Cash And Equivalents Q3 2025 · Mar 31, 2024 $1.2M
Stockholders Equity Q3 2025 · Dec 31, 2024 $6.26M
Stockholders Equity Q3 2025 · Sep 30, 2024 $7.38M
Stockholders Equity Q3 2025 · Mar 31, 2024 $7.32M
Stockholders Equity Q3 2025 · Dec 31, 2023 $9.05M
Stockholders Equity Q3 2025 · Sep 30, 2023 $14.1M
Stockholders Equity Q3 2025 · Mar 31, 2023 $14.91M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.66M
Current Liabilities Q3 2025 · Mar 31, 2024 $2.34M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.82M
Total Liabilities Q3 2025 · Mar 31, 2024 $2.58M
Current Assets Q3 2025 · Dec 31, 2024 $3.05M
Current Assets Q3 2025 · Mar 31, 2024 $3.71M
Total Assets Q3 2025 · Dec 31, 2024 $9.08M
Total Assets Q3 2025 · Mar 31, 2024 $9.9M
Eps Diluted Q3 2025 · Dec 31, 2024 −$0.02
Eps Diluted Q3 2025 · Dec 31, 2024 −$0.08
Eps Diluted Q3 2025 · Dec 31, 2023 −$0.09
Eps Diluted Q3 2025 · Dec 31, 2023 −$0.18
Eps Basic Q3 2025 · Dec 31, 2024 −$0.02
Eps Basic Q3 2025 · Dec 31, 2024 −$0.08
Eps Basic Q3 2025 · Dec 31, 2023 −$0.09
Eps Basic Q3 2025 · Dec 31, 2023 −$0.18
Sga Expense Q3 2025 · Dec 31, 2024 $1.13M
Sga Expense Q3 2025 · Dec 31, 2024 $3.84M
Sga Expense Q3 2025 · Dec 31, 2023 $2.23M
Sga Expense Q3 2025 · Dec 31, 2023 $5.27M
Rd Expense Q3 2025 · Dec 31, 2024 $852K
Rd Expense Q3 2025 · Dec 31, 2024 $2.66M
Rd Expense Q3 2025 · Dec 31, 2023 $903K
Rd Expense Q3 2025 · Dec 31, 2023 $2.92M
Net Income Q3 2025 · Dec 31, 2024 −$1.83M
Net Income Q3 2025 · Dec 31, 2024 −$5.92M
Net Income Q3 2025 · Dec 31, 2023 −$5.59M
Net Income Q3 2025 · Dec 31, 2023 −$10.12M
Operating Income Q3 2025 · Dec 31, 2024 −$1.88M
Operating Income Q3 2025 · Dec 31, 2024 −$6.03M
Operating Income Q3 2025 · Dec 31, 2023 −$3M
Operating Income Q3 2025 · Dec 31, 2023 −$7.63M
Gross Profit Q3 2025 · Dec 31, 2024 $104K
Gross Profit Q3 2025 · Dec 31, 2024 $465K
Gross Profit Q3 2025 · Dec 31, 2023 $133K
Gross Profit Q3 2025 · Dec 31, 2023 $562K
Cost Of Revenue Q3 2025 · Dec 31, 2024 $153K
Cost Of Revenue Q3 2025 · Dec 31, 2024 $476K
Cost Of Revenue Q3 2025 · Dec 31, 2023 $71K
Cost Of Revenue Q3 2025 · Dec 31, 2023 $488K
Revenue Q3 2025 · Dec 31, 2024 $257K
Revenue Q3 2025 · Dec 31, 2024 $941K
Revenue Q3 2025 · Dec 31, 2023 $204K
Revenue Q3 2025 · Dec 31, 2023 $1.05M